annual RepoRt 2011 - Haldex

Consolidated income statement
2011 2010
Continuing discontinued Haldex Continuing discontinued Haldex
amounts in SeK m note operations operations operations operations
net sales 4,030 1,027 5,057 3,710 3,196 6,906
Cost of goods sold 9 -2,967 -768 -3,735 -2,656 -2,491 -5,147
Gross income 1,063 259 1,322 1,054 704 1,758
Selling expenses 9 -420 -39 -459 -475 -121 -596
administrative expenses 9 -256 -86 -342 -285 -219 -504
product development expenses 9 -153 -28 -181 -134 -113 -247
other operating income and expenses 1 -45 -44 -50 -60 -110
Capital gain/loss 24 - 1,904 1,904 - -19 -19
operating income 235 1,965 2,200 110 172 282
Interest income 13 1 14 2 1 3
Interest expense -19 -11 -30 -29 -23 -52
other financial items -12 - -12 -41 -14 -55
earnings before tax 217 1,955 2,172 42 136 178
taxes 10 -75 -19 -94 -13 -34 -47
net income for the year 142 1,936 2,078 29 102 131
Attributable to:
parent Company shareholders 136 1,936 2,072 24 102 126
Minority interests 6 - 6 5 - 5
earnings per share before dilution, SeK 3:08 43:86 46:94 0:55 2:32 2:87
earnings per share after dilution, SeK 3:08 43:86 46:94 0:55 2:32 2:87
average number of shares, thousands 44,133 44,133 44,133 43,840 43,840 43,840
Consolidated statement of
comprehensive income
amounts in SeK m 2011 2010
net profit 2,078 131
other comprehensive income
Change in hedging reserve, after tax -38 7
translation difference -82 -151
Reversal translation difference 72 -9
total other comprehensive loss -48 -153
total comprehensive income/loss 2,030* -22*
* attributable to discontinued operations 1,929 (85).
30 | Haldex annual report 2011